International Biotechnology (IBT) Competitors GBX 658 +2.00 (+0.30%) As of 11:58 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock IBT vs. OCI, RICA, SAIN, CGT, ICGT, IEM, JEO, MUT, APEO, and NBPEShould you be buying International Biotechnology stock or one of its competitors? The main competitors of International Biotechnology include Oakley Capital Investments (OCI), Ruffer Investment (RICA), Scottish American Investment (SAIN), Capital Gearing (CGT), ICG Enterprise Trust (ICGT), Impax Environmental Markets (IEM), European Opportunities Trust (JEO), Murray Income Trust (MUT), abrdn Private Equity Opportunities (APEO), and NB Private Equity Partners (NBPE). These companies are all part of the "asset management" industry. International Biotechnology vs. Its Competitors Oakley Capital Investments Ruffer Investment Scottish American Investment Capital Gearing ICG Enterprise Trust Impax Environmental Markets European Opportunities Trust Murray Income Trust abrdn Private Equity Opportunities NB Private Equity Partners Oakley Capital Investments (LON:OCI) and International Biotechnology (LON:IBT) are both small-cap asset management industry companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership. Is OCI or IBT more profitable? International Biotechnology has a net margin of 90.66% compared to Oakley Capital Investments' net margin of 88.84%. International Biotechnology's return on equity of 13.67% beat Oakley Capital Investments' return on equity.Company Net Margins Return on Equity Return on Assets Oakley Capital Investments88.84% 7.17% 4.33% International Biotechnology 90.66%13.67%3.57% Which has more volatility & risk, OCI or IBT? Oakley Capital Investments has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500. Comparatively, International Biotechnology has a beta of 0.21, suggesting that its share price is 79% less volatile than the S&P 500. Is OCI or IBT a better dividend stock? Oakley Capital Investments pays an annual dividend of GBX 5 per share and has a dividend yield of 1.0%. International Biotechnology pays an annual dividend of GBX 29 per share and has a dividend yield of 4.4%. Oakley Capital Investments pays out 10.0% of its earnings in the form of a dividend. International Biotechnology pays out 27.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Which has higher valuation & earnings, OCI or IBT? Oakley Capital Investments has higher revenue and earnings than International Biotechnology. International Biotechnology is trading at a lower price-to-earnings ratio than Oakley Capital Investments, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOakley Capital Investments£99.08M9.29£88.03M£49.9010.46International Biotechnology£41.82M5.65£37.91M£104.806.28 Does the media refer more to OCI or IBT? In the previous week, Oakley Capital Investments' average media sentiment score of 0.00 equaled International Biotechnology'saverage media sentiment score. Company Overall Sentiment Oakley Capital Investments Neutral International Biotechnology Neutral Do institutionals and insiders have more ownership in OCI or IBT? 50.2% of Oakley Capital Investments shares are owned by institutional investors. Comparatively, 45.2% of International Biotechnology shares are owned by institutional investors. 20.9% of Oakley Capital Investments shares are owned by insiders. Comparatively, 4.2% of International Biotechnology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryOakley Capital Investments beats International Biotechnology on 9 of the 13 factors compared between the two stocks. Get International Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for IBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBT vs. The Competition Export to ExcelMetricInternational BiotechnologyAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£236.36M£1.30B£6.35B£3.02BDividend Yield4.20%4.40%4.20%5.02%P/E Ratio6.2822.2914.03165.88Price / Sales5.652,351.921,730.14285,131.44Price / Cash155.7460.71128.5127.97Price / Book0.861.231.964.46Net Income£37.91M£263.65M£1.24B£5.90B7 Day Performance4.11%0.22%0.80%3.82%1 Month Performance9.67%2.81%4.08%9.81%1 Year Performance-5.73%5.94%19.68%74.29% International Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBTInternational BiotechnologyN/AGBX 658+0.3%N/A-6.3%£236.36M£41.82M6.28N/AOCIOakley Capital InvestmentsN/AGBX 520-0.6%N/A+2.0%£917.34M£99.08M10.42N/ARICARuffer InvestmentN/AGBX 283.50+0.2%N/A+4.4%£912.23M£16.91M103.12N/ASAINScottish American InvestmentN/AGBX 513-0.4%N/A-0.1%£897.02M£75.38M10.29N/ACGTCapital GearingN/AGBX 4,810+0.1%N/A+2.4%£894.54M£17.92M19.56N/AICGTICG Enterprise TrustN/AGBX 1,380-0.7%N/A+7.1%£891.87M£55.63M27.56N/AIEMImpax Environmental MarketsN/AGBX 383-1.0%N/A-0.8%£889.13M£1.35M-95.27N/APositive NewsJEOEuropean Opportunities TrustN/AN/AN/AN/A£886.70M-£62.33M-12.93N/AMUTMurray Income TrustN/AGBX 886.50+0.2%N/A+1.4%£885.69M£97.96M9.77147,000Dividend CutHigh Trading VolumeAPEOabrdn Private Equity OpportunitiesN/AN/AN/AN/A£880.29M£80.21M1,435.00N/ANBPENB Private Equity PartnersN/AGBX 1,484-0.4%N/A-12.0%£860.73M£12.90M-38.92N/A Related Companies and Tools Related Companies Oakley Capital Investments Competitors Ruffer Investment Competitors Scottish American Investment Competitors Capital Gearing Competitors ICG Enterprise Trust Competitors Impax Environmental Markets Competitors European Opportunities Trust Competitors Murray Income Trust Competitors abrdn Private Equity Opportunities Competitors NB Private Equity Partners Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IBT) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share International Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBT Stock Alerts